Approvals/TGA/DESVENLAFAXINE MR APOTEX desvenlafaxine 100mg (as succinate monohydrate) modified release tablets blister

Approved

STANDARD

DESVENLAFAXINE MR APOTEX desvenlafaxine 100mg (as succinate monohydrate) modified release tablets blister

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8f79e0d096dc10ff
Product Name: DESVENLAFAXINE MR APOTEX desvenlafaxine 100mg (as succinate monohydrate) modified release tablets blister
Artg Id: 215822
Artg Name: DESVENLAFAXINE MR APOTEX desvenlafaxine 100mg (as succinate monohydrate) modified release tablets blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2014-10-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8f79e0d096dc10ff

Type

Standard